| |
| |
|
| Insider
Information: |
Chardonnet Laurent |
| Relationship: |
|
| City: |
Wilmington |
| State: |
DE |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
51,336 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$171,860 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
51,336 |
|
|
| Total
Value |
$171,860 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Incyte Corp |
INCY |
Vice President and Tre... |
2015-03-30 |
2,905 |
|
0 |
Premium* |
|
|
Axcella Health Inc. |
AXLA |
Chief Financial Officer |
2020-10-30 |
6,266 |
2020-01-24 |
0 |
Premium* |
|
|
Prelude Therapeutics Inc |
PRLD |
|
2023-05-23 |
42,165 |
2021-12-13 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
33 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AXLA |
Axcella Health Inc. |
Chief Financial Officer |
• – – |
2020-01-27 |
4 |
B |
$4.94 |
$1,739 |
D/D |
352 |
665 |
2.66 |
- |
|
| AXLA |
Axcella Health Inc. |
Chief Financial Officer |
• – – |
2020-01-31 |
4 |
B |
$4.94 |
$14,820 |
D/D |
3,000 |
3,665 |
2.74 |
- |
|
| AXLA |
Axcella Health Inc. |
Chief Financial Officer |
• – – |
2020-10-30 |
4 |
A |
$3.60 |
$9,364 |
D/D |
2,601 |
6,266 |
0 |
- |
|
| PRLD |
Prelude Therapeutics Inc |
Chief Financial Officer |
• – – |
2021-12-13 |
4 |
A |
$12.28 |
$61,400 |
D/D |
5,000 |
8,000 |
0 |
- |
|
| PRLD |
Prelude Therapeutics Inc |
Chief Financial Officer |
• – – |
2022-03-21 |
4 |
A |
$7.51 |
$48,815 |
D/D |
6,500 |
14,500 |
0 |
- |
|
| PRLD |
Prelude Therapeutics Inc |
Chief Financial Officer |
• – – |
2022-06-01 |
4 |
B |
$4.23 |
$42,300 |
D/D |
10,000 |
24,500 |
0.01 |
- |
|
| PRLD |
Prelude Therapeutics Inc |
Chief Financial Officer |
• – – |
2022-12-08 |
4 |
B |
$4.76 |
$47,600 |
D/D |
10,000 |
35,873 |
0.01 |
- |
|
| PRLD |
Prelude Therapeutics Inc |
Chief Financial Officer |
• – – |
2023-05-23 |
4 |
B |
$5.50 |
$27,500 |
D/D |
5,000 |
42,165 |
0.01 |
- |
|
33 Records found
|
|
Page 2 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
